It is reported that the expressions of TLR2, TLR4, TLR9, MyD88, and NF-κB were elevated in PBMC of patients with GBS (Wang et al., 2012; Du et al., 2015). This evidence concerns the gene TLR9 and Guillain-Barre syndrome.